Csenge Advisory Group’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,623
| Closed | -$530K | – | 767 |
|
|
2025
Q3 | $530K | Sell |
3,623
-1,135
| -24% | -$172K | 0.03% | 417 |
|
|
2025
Q2 | $802K | Sell |
4,758
-219
| -4% | -$34.7K | 0.04% | 312 |
|
|
2025
Q1 | $740K | Sell |
4,977
-295
| -6% | -$49.1K | 0.04% | 306 |
|
|
2024
Q4 | $859K | Buy |
5,272
+39
| +0.7% | +$6.97K | 0.05% | 296 |
|
|
2024
Q3 | $995K | Sell |
5,233
-467
| -8% | -$86K | 0.05% | 277 |
|
|
2024
Q2 | $988K | Buy |
5,700
+71
| +1% | +$11.8K | 0.06% | 253 |
|
|
2024
Q1 | $953K | Sell |
5,629
-1
| -0% | -$187 | 0.05% | 274 |
|
|
2023
Q4 | $1.11M | Buy |
5,630
+236
| +4% | +$41.8K | 0.07% | 212 |
|
|
2023
Q3 | $938K | Buy |
5,394
+720
| +15% | +$131K | 0.06% | 218 |
|
|
2023
Q2 | $805K | Sell |
4,674
-109
| -2% | -$18.8K | 0.05% | 259 |
|
|
2023
Q1 | $796K | Buy |
4,783
+100
| +2% | +$16.4K | 0.06% | 250 |
|
|
2022
Q4 | $686K | Sell |
4,683
-280
| -6% | -$41.4K | 0.05% | 274 |
|
|
2022
Q3 | $736K | Buy |
4,963
+64
| +1% | +$10.7K | 0.06% | 256 |
|
|
2022
Q2 | $842K | Sell |
4,899
-190
| -4% | -$32.9K | 0.07% | 240 |
|
|
2022
Q1 | $960K | Sell |
5,089
-211
| -4% | -$41.7K | 0.08% | 226 |
|
|
2021
Q4 | $1M | Sell |
5,300
-35
| -0.7% | -$7.67K | 0.09% | 193 |
|
|
2021
Q3 | $1.05M | Buy |
5,335
+35
| +0.7% | +$7.06K | 0.09% | 210 |
|
|
2021
Q2 | $1M | Buy |
5,300
+3,017
| +132% | +$524K | 0.09% | 193 |
|
|
2021
Q1 | $365K | Sell |
2,283
-5,075
| -69% | -$804K | 0.04% | 347 |
|
|
2020
Q4 | $1.22M | Sell |
7,358
-170
| -2% | -$27.6K | 0.15% | 116 |
|
|
2020
Q3 | $1.22M | Sell |
7,528
-310
| -4% | -$47.6K | 0.17% | 103 |
|
|
2020
Q2 | $1.07M | Sell |
7,838
-159
| -2% | -$20.8K | 0.15% | 111 |
|
|
2020
Q1 | $941K | Buy |
7,997
+447
| +6% | +$58.9K | 0.25% | 86 |
|
|
2019
Q4 | $999K | Sell |
7,550
-103
| -1% | -$12.8K | 0.25% | 87 |
|
|
2019
Q3 | $953K | Buy |
7,653
+1,243
| +19% | +$150K | 0.26% | 81 |
|
|
2019
Q2 | $727K | Sell |
6,410
-2,253
| -26% | -$236K | 0.25% | 74 |
|
|
2019
Q1 | $872K | Buy |
8,663
+643
| +8% | +$58.4K | 0.3% | 64 |
|
|
2018
Q4 | $686K | Buy |
8,020
+5,261
| +191% | +$474K | 0.25% | 79 |
|
|
2018
Q3 | $255K | Buy |
2,759
+7
| +0.3% | +$621 | 0.1% | 131 |
|
|
2018
Q2 | $238K | Buy |
2,752
+352
| +15% | +$29.7K | 0.09% | 211 |
|
|
2018
Q1 | $200K | Buy |
+2,400
| New | +$189K | 0.07% | 263 |
|
Other funds holding ZTS
Csenge Advisory Group's ZTS Position: Q4 2025 in Review
Csenge Advisory Group sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 3,623 shares — an estimated $530K sold.
Csenge Advisory Group first reported a position in ZTS in Q1 2018 and held it in 31 quarters. The position peaked at $1.22M in Q4 2020. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.
- Csenge Advisory Group reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
- Csenge Advisory Group sold 3,623 Zoetis shares in Q4 2025, an estimated $530K.
- Csenge Advisory Group first reported a position in Zoetis in Q1 2018 and held it in 31 quarters.
- Csenge Advisory Group's Zoetis position peaked at $1.22M in Q4 2020.
- 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.
Based on Csenge Advisory Group's 13F filing for Q4 2025, filed 6 Feb 2026.